Comparing Raloxifene vs Reclast
| Raloxifene | Reclast (zoledronic acid) |
|
|---|
| Raloxifene | Reclast (zoledronic acid) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Raloxifene is not a hormone but it mimics estrogen and may be used to treat osteoporosis in postmenopausal women or to lower the risk of invasive breast cancer in women with osteoporosis. Hot... View more |
Prescription only
Reclast may be used to treat or prevent osteoporosis caused by menopause, steroid use, or gonadal failure, in the treatment of Paget's disease, and to increase bone mineral density in men. Reclast... View more |
Related suggestions Osteoporosis
Prevention of Osteoporosis
|
|||||||||||||||
| More about Raloxifene | More about Reclast (zoledronic acid) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Raloxifene has an average rating of 5.8 out of 10 from a total of 18 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 33% reported a negative effect. |
Reclast has an average rating of 5.1 out of 10 from a total of 275 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 43% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Raloxifene side effects |
View all Reclast side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Raloxifene prices |
View all Reclast prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Evista | Other zoledronic acid brands include: Aclasta, Zometa | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
27.7 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 46 drugs are known to interact with Raloxifene:
|
A total of 123 drugs are known to interact with Reclast:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 09, 1997 |
August 17, 2007 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.